NCT05996588View on ClinicalTrials.gov

Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

November 25, 2022

Study Completion Date

November 25, 2022

Conditions
Sedation Complication
Interventions
DRUG

Propofol 1 % Injectable Suspension

Propofol 1 % Injectable Suspension at a rate of 50 microgram/kg/min intravenously

DRUG

Sevoflurane

Sevoflurane inhalation anaesthetic at a concentration of 4-5% to achieve a MAC of 0.25

Trial Locations (1)

74200

Syed Muhammad Abbas, Karachi

All Listed Sponsors
lead

Sindh Institute of Urology and Transplantation

OTHER

NCT05996588 - Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP | Biotech Hunter | Biotech Hunter